Research and Markets has added GlobalData’s latest report titled “Blood Glucose Monitoring Devices (Meters, Test Strips, Lancets) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" to its portfolio.
GlobalData's report on blood glucose monitoring devices provides a detailed analysis and crucial information on the global market, including the competitive landscape, the latest market trends and the landscape. The report provides insights on the trends that affect the blood glucose monitoring devices market and also reviews technological offerings. The market segments covered in the report includes lancets, blood glucose test strips and blood glucose meters.
The report indicates that the value of the global blood glucose monitoring devices market in 2010 was $8.9 billion and has increased from the $6.2 billion valuation in 2003, growing steadily at a CAGR of 5.2%. In 2010, the value of the test strips market segment increased to $7.9 billion at a CAGR of 5.3% since 2003.
Analysts forecast that from 2010 to 2017, with a CAGR growth of 4.5%, the blood glucose monitoring devices market will reach $12.2 billion, while the test strips market segment is predicted to reach $10.9 billion by 2017.
The market growth is attributed to the high population of diabetic patients who monitor their condition using blood glucose monitoring devices. The International Diabetes Federation reports that in 2011, 366 million people were diabetic across the world.
The report details the markets by geographical areas and details the blood sugar monitoring devices markets of the UK, the US, Canada, France, Spain, Germany, Italy, China, Japan, India, Brazil and Australia. The key market players detailed in the report include Bayer Healthcare, Abbott Laboratories, LifeScan and F. Hoffmann-La Roche.
Source: http://www.researchandmarkets.com